Serum biomarker panel may help predict Crohn’s diagnosis

A panel of serum antibodies and proteins helped identify patients who later received a diagnosis of Crohn’s disease within 5 years, according to research published in Gastroenterology.Jean-Frederic Colombel, MD, PhD, of the Icahn School of Medicine at Mount Sinai, and colleagues wrote that inflammatory bowel disease appears to be like other immune-mediated diseases, in that it is proceeded by an asymptomatic, pre-clinical period.“Gaining insight into this phase could allow disease prediction,” they wrote. “The PREDICTS (Proteomic Evaluation and Discovery in an IBDRead More